Trial of Orca-T Following Reduced Intensity or Nonmyeloablative Conditioning in Patients With Acute Myeloid Leukemia or Myelodysplastic Syndrome
Orca Biosystems, Inc.
Orca Biosystems, Inc.
Novartis
Taiho Oncology, Inc.
Novartis
Takeda
Ossium Health, Inc.
Ossium Health, Inc.
Novartis
NextCure, Inc.
Novartis
Massive Bio, Inc.
Incyte Corporation
Constellation Pharmaceuticals
Bristol-Myers Squibb
BlossomHill Therapeutics
Vor Biopharma
Celgene
Cogent Biosciences, Inc.
Novartis
Hikma Pharmaceuticals LLC
GlaxoSmithKline
Cyclacel Pharmaceuticals, Inc.
Ono Pharmaceutical Co. Ltd
Takeda
Ipsen
Cyclacel Pharmaceuticals, Inc.
Bellicum Pharmaceuticals
Bellicum Pharmaceuticals
Chongqing Precision Biotech Co., Ltd
Bellicum Pharmaceuticals
Bellicum Pharmaceuticals
Bellicum Pharmaceuticals
Celgene
Takeda
Taiga Biotechnologies, Inc.
Bayer
Pfizer
Cyclacel Pharmaceuticals, Inc.
Incyte Corporation
Takeda
Maxinovel Pty., Ltd.
Novartis
Novartis
Novartis
Takeda
iCell Gene Therapeutics
Pfizer
Novartis
Hikma Pharmaceuticals LLC
Novartis